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Abstract Kv1.3 and IKCa1 lymphocyte potassium
channels have been implicated as important targets of
selective immunomodulation. We compared the alterations
in cytokine production upon selective inhibition of Kv1.3
or IKCa1 channels (by MGTX and TRAM, respectively) in
healthy donors (HD), RA and AS patients. We also
determined calcium influx kinetics and its sensitivity to
Kv1.3 and IKCa1 channel inhibition following PHA acti-
vation in CD4, Th1, Th2 and CD8 cells as well as mono-
cytes. The application of TRAM resulted in a lower
production of TNF-a and IL1-RA in all three study groups.
Inhibition by TRAM had contrary effects on the production
of IL-1b and IL-5: While their production was increased by
PBMCs of RA patients, this effect was not observed in HD
and AS PBMCs. While treatment with MGTX resulted in a
similar decrease in calcium influx in the CD4 and Th2
subsets across all study groups, TRAM treatment had
opposite effects on RA and HD samples: It decreased
calcium influx in the Th2 and CD8 subsets in RA, while
only Th1 cells were affected in HDs. The effects of IKCa1
channel inhibition are controversial in samples of RA and
AS patients, since it shifts the inflammatory balance into
the pro-inflammatory direction.
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Introduction
Voltage-sensitive Kv1.3 and calcium-dependent IKCa1
lymphocyte potassium channels have been implicated as
important targets of selective immunomodulation in
autoimmune disorders. The transient increase in the cyto-
plasmic-free calcium level, which is a prerequisite of the
downstream events of lymphocyte activation, is maintained
by the function of potassium channels. They conserve the
electrochemical potential gradient via the efflux of potas-
sium from cytoplasm [1]. The relationship between the
influx of calcium through the cell membrane and the efflux
of potassium makes proliferation and activation of lym-
phocytes sensitive to pharmacological inhibition of Kv1.3
and IKCa1 channels and provides a potential opportunity
for targeted intervention.
Earlier studies reported that disease-associated autore-
active T cells from patients with rheumatoid arthritis (RA)
are mainly effector memory T cells (TEM cells) with
elevated Kv1.3 channel expression. In contrast, T cells with
other antigen specificities from these patients are predom-
inantly naive or central memory T cells (TCM cells),
expressing low levels of Kv1.3 that upregulate IKCa1
channels upon activation. Therefore, selective inhibition of
Kv1.3 channels was implicated to specifically suppress
disease-associated, autoantigen-specific TEM cells, while
sparing other T cell subsets. Indeed, Kv1.3 inhibitors
ameliorated pristane-induced arthritis in rats without sys-
temic toxic effects [2]. Previous data indicated that specific
inhibition of the Kv1.3 channel indeed acts differentially
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on calcium influx kinetics in major peripheral blood lym-
phocyte subsets of RA patients. Unlike in healthy indi-
viduals, Th2, and in particular, CD8 cells are inhibited
more dominantly than Th1 and CD4 cells. However, the
inhibitory effect does not seem to be as specific as reported
in case of autoreactive T cells, since Th2 cells are affected
as well [3].
Limited data are available on the effects of lymphocyte
potassium channel inhibition on cytokine production and
its relation to the regulation of calcium influx, especially in
cytokine-producing Th1 and Th2 subsets. Over the recent
years, targeted therapies have been developed to prevent
the harmful effect of certain cytokines, such as TNF-a, IL-6
or IL-1b. The success of these biological therapies
demonstrates the need to further study interventional
methods influencing cytokine production.
In this study, we aimed to compare the alterations in
cytokine production patterns caused by selective inhibition
of the Kv1.3 or IKCa1 channels in healthy donors, as well
as in patients with RA or ankylosing spondylitis (AS). To
evaluate the mechanisms that potentially contribute to
these alterations, we also investigated calcium influx
kinetics in peripheral blood mononuclear cells and the
effects of inhibitors of Kv1.3 and IKCa1 potassium
channels.
Materials and methods
Patients
Peripheral blood samples were collected from 15 RA
patients, 10 AS patients and 8 healthy donors (HD). Clin-
ical data of participants are summarized in Table 1. HD
had a negative history of rheumatic symptoms and negative
status upon detailed physical and laboratory examination.
Written informed consent was obtained from all subjects,
and our study was reviewed and approved by the ethics
committee of the institution. The study adhered to the
tenets of the most recent revision of the Declaration of
Helsinki.
Cytokine levels
For the measurement of cytokines from supernatants,
5 9 105 PBMCs were cultured in RPMI medium supple-
mented with CaCl2 (calcium concentration: 2 mM) over
48 h in the presence of 160 nM PMA and in the presence
or absence of 4 nM margatoxin (MGTX) or 240 nM tri-
arylmethane-34 (TRAM). Then, supernatants were frozen
at -80 C until analysis. Cytokine concentrations (IL-1b,
IL1-RA, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, IL-
17A/F, IFN-g, TNF-a) were determined using the eBio-
science FlowCytomix multiplex array according to the
manufacturer’s instructions.
Calcium flux
Measurements were taken as described earlier [3]. Briefly,
peripheral blood mononuclear cells (PBMCs) were isolated
by a standard density gradient centrifugation from 9 mL of
freshly drawn peripheral venous blood and afterward kept
in RPMI medium supplemented with CaCl2 (calcium
concentration: 2 mM) throughout the following steps of the
procedure. PBMCs were then incubated with the following
conjugated anti-human monoclonal antibodies: anti-CD4
PE-Cy7, anti-CD8 APC-Cy7, anti-CXCR3 APC (for the
determination of Th1 cells) and anti-CCR4 PE (for the
determination of Th2 cells) (all from PharMingen, San
Diego, CA, USA) according to the manufacturer’s
instructions.
Table 1 Clinical characteristics of study participants
Characteristics Healthy donors
n = 8
RA patients
n = 15
AS patients
n = 10
Age (years) 50.0 ± 15.1 53.2 ± 14.4 52.8 ± 14.0
Gender (male/female) 4/4 4/11 8/2
Disease duration (years) – 13.2 ± 11.5 15.8 ± 13.8
CRP (mg/L) – 2.8 ± 2.1 1.9 ± 1.5
Number of patients receiving anti-TNF therapy – 15 (100 %) 10 (100 %)
DAS28 – 2.4 ± 1.0 –
BASDAI – – 3.2 ± 2.1
Number of anti-CCP-negative patients – 3 (20 %) –
Number of HLA-B27-positive patients – – 8 (80 %)
Data are expressed as mean ± SD for continuous variables and as number (percent) for categorical variables
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For monitoring cytoplasmic calcium levels, PBMCs
were loaded with calcium-sensitive Fluo-3 and Fura Red
dyes according to the manufacturer’s recommendations
(Invitrogen, Carlsbad, CA, USA). PBMCs were incubated
in the presence or absence of 4 nM MGTX or 240 nM
TRAM. After recording a baseline for 2 min, cells were
activated with 20 lg phytohemagglutinin (PHA) and the
measurement was continued directly afterward in a kinetic
manner for 15 min employing a flow cytometer (Beckman
Coulter GalliosTM, Miami, FL, USA). Recordings were
evaluated with specific software (FacsKin, Budapest,
Hungary) which is based on the calculation of a logistic
function for each measurement [4].
Statistics
Data are expressed as mean ± SEM. Comparisons were
made with unpaired and paired Student’s t tests. p values
\0.05 were considered significant. Statistics were calcu-
lated with Microsoft Excel.
Results
Cytokine levels
Treatment with MGTX had no significant influence on
cytokine production in any of the study groups (Fig. 1a–e).
On the contrary, upon treatment with TRAM, the produc-
tion of IL-1b was decreased in HD samples, while the
opposite effect was observed in RA samples (Fig. 1a). The
production of IL-5 was increased by treatment with TRAM
in RA patients; however, this effect was not observed in
HD and AS (Fig. 1b). Treatment with TRAM decreased the
production of TNF-a and IL1-RA by PBMCs in all study
groups (Fig. 1c, d). IL-6, IFN-g, IL-10, IL-13, IL-2, IL-
12p70, IL-4 and IL-17A/F levels did not show relevant
inhibition with any treatment (Fig. 1e).
Calcium flux
Figure 2a shows an example of calcium influx measure-
ments using flow cytometry. In this plot, each dot corre-
sponds to a single cell. AUC values were calculated after
fitting a logistic function on each measurement using the
FacsKin software. The total amount of calcium influx,
represented by AUC values in the histograms, was
decreased by MGTX in the Th2 subset of all three study
groups (Fig. 2c). On the contrary, TRAM treatment had
opposite effects on RA and HD samples: It decreased
calcium influx in the Th1 subset of HDs and in Th2 and
CD8 cells of RA patients (Fig. 2b–d). Calcium influx was
not altered in monocytes in any of the study groups
(Fig. 2e).
Discussion
In this study, we have demonstrated that PBMCs isolated
from RA and AS patients react with a different pattern of
alterations in cytokine production and calcium influx
kinetics compared to HDs. While treatment with MGTX
did not influence cytokine production, the application of
TRAM resulted in a lower production of TNF-a and IL1-
RA in all three study groups. Interestingly, inhibition by
TRAM had contrary effects on the production of IL-1b and
Fig. 1 Concentration of selected cytokines in supernatants of PBMCs
isolated from healthy donors (HD), rheumatoid arthritis (RA) and
ankylosing spondylitis (AS) patients. PBMCs were cultured over 48 h
in the presence of 160 nM PMA and in the presence or absence of
4 nM margatoxin (MGTX) or 240 nM triarylmethane-34 (TRAM).
Data are expressed as mean ± SEM
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IL-5: While their production was increased by PBMCs of
RA patients, this effect was not observed in HD and AS.
Likewise, while treatment with MGTX resulted in a similar
decrease in calcium influx in the CD4 and Th2 subsets
across all study groups, TRAM treatment had opposite
effects on RA and HD samples: It decreased calcium influx
in the Th2 and CD8 subsets, while only Th1 cells were
affected in HDs. The effects of IKCa1 channel inhibition
are controversial in samples of RA and AS patients.
Although TRAM decreased TNF-a levels in both patient
groups, showing a beneficial therapeutic effect, it also
decreased IL1-RA levels and increased IL-1b levels in RA,
which contributes to a pro-inflammatory response already
present in this disease, as observed before [5].
Earlier animal data from Beeton et al. indicated that
Kv1.3 inhibitors (SL5 and PAP1) not only suppress cal-
cium signaling and proliferation of autoantigen-specific
TEM cells, but also decrease their cytokine production
while sparing other classes of T cells. SL5 and PAP1
inhibited IL-2 and IFN-g production by T cells isolated
from synovial fluid of a rat model of RA (mainly TEM
cells) more effectively than T cells isolated from peripheral
blood of these animals (mainly naı¨ve and TCM cells).
However, these Kv1.3 inhibitors were less effective in
suppressing the production of TNF-a and IL-4 [2]. Hu et al.
[1] also demonstrated the inhibition of IFN-g and IL-5
production by Kv1.3 blockers (MGTX and ShK) in anti-
CD3/anti-CD28 stimulated freshly isolated human CD4
cells and the inhibition of IFN-g production in TEM cells
generated from freshly isolated human CD4 cells. The
reason for the differences observed in the effects of Kv1.3
channel inhibition between these earlier trials and our
results might partly be due to differences in the method of
cell stimulation and inhibition. Importantly, we here pro-
vide the first data on the effects of Kv1.3 and IKCa1
inhibitors on human patient samples in RA and AS. While
it is not clear how the in vitro observed effects of the
applied inhibitors correspond to their immunomodulatory
effects in vivo, an advantage of our method over single-
cell-based techniques is that physiological cell-to-cell
communication between T cell subsets is maintained in our
experimental setup, since individual cell subsets are gated
virtually during the evaluation.
A limitation of our study might be the fact that we used
different stimuli to measure cytokine production and cal-
cium influx in the presence or absence of potassium
channel inhibitors. PMA is a more robust stimulus of
cytokine production compared to PHA. Although the main
effect of PMA is the activation of protein kinase C, it is
also known to influence calcium homeostasis [6]. Our
supplementary measurements of cytokine production using
PHA as a stimulus showed similar but less remarkable
tendencies of alterations in cytokine production upon
potassium channel inhibition (data not shown). However,
this fact does not exclude the possibility that the applied
inhibitors might also interact with other cellular signaling
mechanisms.
In summary, the application of lymphocyte potassium
channel inhibitors has controversial effects on cytokine
production and calcium influx patterns in patients with RA
Fig. 2 a Example of calcium influx measurement using flow
cytometry. In this plot, each dot corresponds to a single cell. The
relative fluorescence ratio of the applied calcium-binding dyes,
corresponding to the level of cytoplasmic calcium, is represented on
the vertical axis. Median fluorescence values for each time point,
represented in red, were used for fitting a logistic function on each
measurement. b–e Area under the curve (AUC) values of calcium
influx kinetics in PBMC subsets isolated from healthy donors (HD),
rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients in
the presence or absence of 4 nM margatoxin (MGTX) or 240 nM
triarylmethane-34 (TRAM). Data are expressed as mean ± SEM
(Color figure online)
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and AS, questioning its therapeutic relevance. TRAM
decreases the secretion of TNF-a and increases the secre-
tion of the Th2 cytokine IL-5 in patients with RA. This
would contribute to the shift of the immune balance toward
less tissue damage and cellular paucity in RA. Neverthe-
less, TRAM increases the secretion of IL-1b and at the
same time decreases that of IL1-RA which is unfavorable,
since it supports an IL-1b-mediated pro-inflammatory
response. Additionally, TRAM also inhibits the short-term
activation of Th2 lymphocytes in RA, leaving that of Th1
cells unaffected, probably further contributing to a shift of
the inflammatory balance to a pro-inflammatory profile.
The differences observed in cytokine response upon inhi-
bition of Kv1.3 and IKCa1 channels support the differential
pathomechanisms of RA and AS.
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